secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2022-05-09T23:59:59+00:00
Accession:  0000883984-22-000029
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q1 revenue $543M, GAAP net loss $38.1M, adjusted EPS $1.82
----------------------------------------------------------------------

- Revenue $543.1M, up 71% from $318.0M in Q1 2021.
- GAAP net loss of $38.1M ($1.61 per diluted share) vs net income of $23.7M ($1.09) in Q1 2021.
- Adjusted diluted EPS $1.82, up from $1.62; adjusted EBITDA $84.9M vs $57.8M.
- GAAP gross margin declined to 31% from 35% in Q1 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398422000029/0000883984-22-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398422000029/icui-20220509.htm
  HTML page:      https://secwatch.observer/filing/0000883984-22-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer